Abu Dhabi has set its sights on Belgium, as a leading global pharmaceutical hub, to establish a global distribution corridor to serve the world in vaccine delivery and future life science needs. The collaboration builds on the capabilities of Abu Dhabi’s healthcare sector as a leading life sciences hub and the efforts of the HOPE
Consortium in providing vaccine solutions for the world.
This initiative entailed a delegation visit from Belgium to Abu Dhabi, hosted by the Department of Health – Abu Dhabi (DoH). The visit saw the signing of two declarations of collaboration between Belgium and Abu Dhabi.
The first agreement was between the HOPE Consortium, Abu Dhabi Airports Company (ADAC), Brussels Airport Company and Pharma.Aero. Led by the Department of Health – Abu Dhabi, the regulator of the healthcare sector in the emirate, the collaboration aims to establish a fully compliant origin-to-destination pharma air corridor between Abu Dhabi and Brussels Airports. The dedicated pharma trade lane will unite key compliant and sector certified supply chain stakeholders, including forwarders and ground handling agents.
Earlier this year, a delegation from the HOPE Consortium met with pharmaceutical industry stakeholders in Brussels to showcase Abu Dhabi’s global vaccine distribution success. Thanks to its network of partners, the HOPE Consortium has handled over 200 million doses of Covid-19 vaccines, contributing to vaccination programmes in over 40 global destinations.
Western Europe currently ranks as the world’s second-largest pharmaceutical export market with a total export value of nearly EUR 42 billion in 2020. “, Brussels Airport is the leading hub serving the pharmaceutical and life sciences industry in Europe with over 750 million vaccines handled at the airport, serving 60 destinations worldwide” said Nathan De Valck, head of cargo at Brussels Airport.
The development of the dedicated Pharma Air Corridor will leverage API-IoT devices- webforms-internet shared with all relevant stakeholders to monitor pharma shipments closely. “Our relationship with Etihad Cargo and the HOPE Consortium sharing best practices makes us confident that the corridor will promote commitment for transparency with customers and stakeholders.” said Nathan De Valck who also serves as Chairman of
Pharma.Aero.
The other declaration of collaboration was signed by the HOPE Consortium, Pharma.Aero, Khalifa University of Science and Technology and the University of Antwerp to host the second edition of the “Pharma Logistics Masterclass”, a course focused on critical challenges and developments in pharma supply chains and logistics, by Khalifa University in Abu Dhabi from 5th to 9th September 2022.